Merck Sharp & Dohme Corp.;MSD R & D (China) Co. Ltd.
发明人:
申请号：
EP15845304.3
公开号：
EP3197455A4
申请日:
2015.09.23
申请国别(地区):
EP
年份:
2018
代理人:
摘要：
The present invention concerns a compound of formula I or a pharmaceutically acceptable salt thereof, which inhibit HIF prolyl hydroxylase, their use for enhancing endogenous production of erythropoietin, and for treating conditions associated with reduced endogenous production of erythropoietin such as anemia and like conditions, as well as pharmaceutical compositions comprising such a compound and a pharmaceutical carrier.
